HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Torrisi Selected Research

Docetaxel (Taxotere)

9/2006A phase II study of primary dose-dense sequential doxorubicin plus cyclophosphamide and docetaxel in cT4 breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R Torrisi Research Topics

Disease

19Breast Neoplasms (Breast Cancer)
08/2013 - 01/2000
11Neoplasms (Cancer)
08/2013 - 01/2000
4Urinary Bladder Neoplasms (Bladder Cancer)
10/2000 - 01/2000
2Carcinogenesis
01/2001 - 08/2000
1Male Breast Neoplasms (Male Breast Cancer)
04/2011
1Wounds and Injuries (Trauma)
03/2010
1Inflammatory Breast Neoplasms
03/2010
1Cardiovascular Diseases (Cardiovascular Disease)
09/2001
1Endometrial Neoplasms (Endometrial Cancer)
09/2001
1Aneuploidy (Aneuploid)
10/2000
1Leukoplakia
05/2000
1Ovarian Neoplasms (Ovarian Cancer)
05/2000
1Colorectal Neoplasms (Colorectal Cancer)
01/2000

Drug/Important Bio-Agent (IBA)

5FenretinideIBA
01/2001 - 01/2000
4Biomarkers (Surrogate Marker)IBA
11/2004 - 01/2000
4Insulin-Like Growth Factor I (IGF-1)IBA
12/2001 - 01/2000
3Letrozole (Femara)FDA LinkGeneric
11/2008 - 09/2006
3TamoxifenFDA LinkGeneric
07/2008 - 01/2001
3RetinoidsIBA
01/2001 - 08/2000
3Insulin-Like PeptidesIBA
01/2001 - 01/2000
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2012 - 09/2006
2human ERBB2 proteinIBA
10/2010 - 07/2008
2Progesterone Receptors (Progesterone Receptor)IBA
10/2010 - 09/2007
2Capecitabine (Xeloda)FDA Link
03/2010 - 11/2008
2Biological ProductsIBA
11/2008 - 09/2007
2Triptorelin Pamoate (Trelstar)FDA Link
11/2008 - 09/2006
2Insulin-Like Growth Factor Binding Protein 3IBA
12/2001 - 08/2000
2Raloxifene Hydrochloride (Evista)FDA Link
12/2001 - 01/2001
2DNA (Deoxyribonucleic Acid)IBA
10/2000 - 05/2000
1Methotrexate (Mexate)FDA LinkGeneric
01/2012
1Fulvestrant (Faslodex)FDA Link
04/2011
1Estrogen ReceptorsIBA
10/2010
1Phenobarbital (Luminal)FDA Link
10/2010
1Oxytocin (Pitocin)FDA LinkGeneric
03/2010
1Lapatinib (GW572016)FDA Link
03/2010
1Vinorelbine (Navelbine)FDA LinkGeneric
11/2008
1Bevacizumab (Avastin)FDA Link
11/2008
1Angiogenesis InhibitorsIBA
11/2008
1exemestane (Aromasin)FDA Link
07/2008
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
09/2007
1AnthracyclinesIBA
09/2006
1Docetaxel (Taxotere)FDA Link
09/2006
1Taxoids (Taxanes)IBA
09/2006
1Doxorubicin (Adriamycin)FDA LinkGeneric
09/2006
1Selective Estrogen Receptor Modulators (SERM)IBA
01/2001
1Insulin-Like Growth Factor II (Somatomedin A)IBA
08/2000
1Vitamin A (Retinol)FDA LinkGeneric
01/2000
1MitogensIBA
01/2000
1Pharmaceutical PreparationsIBA
01/2000

Therapy/Procedure

7Drug Therapy (Chemotherapy)
08/2013 - 09/2006
6Therapeutics
11/2008 - 11/2004
4Chemoprevention
01/2001 - 01/2000
2Secondary Prevention
01/2001 - 05/2000
1Combined Modality Therapy
06/2008
1Aftercare (After-Treatment)
08/2000
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2000